DSIP vs Epitalon
Updated 6 sources
Key differences
- 1Epitalon is pitched as slow pineal and body-clock support, with 2 to 3 weeks to onset and periodic 10 to 20 day courses. DSIP is used nightly for an acute effect.
- 2In July 2026 an FDA advisory panel backed epitalon for compounding, by a reported 7 to 5 with 1 abstention, and voted DSIP down.
Side by side
Facts from each record, in the same words as their own pages.
| DSIP | Epitalon | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
6 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- Jain et al. 2026, epitalon and epithalamin narrative review (full text)PMC · checked Oct 23, 2026
Regulatory4
- FDA advisory committee backs two more peptides, rejects one for compounding list (July 24, 2026)RAPS, via a news report · checked Oct 24, 2026
- FDA Briefing Document, PCAC July 23-24, 2026: Emideltide-related bulk drug substancesFDA · checked Oct 23, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated April 22, 2026)FDA (Internet Archive copy) · checked Oct 24, 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C ActFDA · checked Oct 24, 2026
Competitor guide1
- Peptides for sleeppeptidesexplorer.com · checked Oct 23, 2026